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Background and Aim: We previously reported that mucosal defect involving over 2 
three-fourths of the circumference of the esophagus after endoscopic mucosal resection 3 
(EMR) is a risk factor for the development of the stricture. Although endoscopic balloon 4 
dilation (EBD) is a useful procedure to relieve the stricture, there is no standard strategy for 5 
preventing development of the stricture. The aim of this study was to evaluate the efficacy 6 
and the safety of preventive EBD. 7 
Methods: From 1993 to 2008, 41 consecutive patients with extensive mucosal defect 8 
involving over three-fourths of the esophageal circumference after EMR or endoscopic 9 
submucosal dissection (ESD) were investigated. Preventive EBD was performed for 29 cases 10 
within one week just after EMR/ESD and was repeated once a week until the mucosal defect 11 
was completely healed. The remaining 12 cases were not underwent preventive EBD and 12 
used as a historical control. If post-EMR/ESD stricture developed regardless of preventive 13 
EBD, conventional EBD was given repeatedly until the stricture was completely relieved. 14 
Results: Preventive EBD decreased the incidence of stricture [59% vs 92%, p=0.04], 15 
reduced the severity of stricture [(2mm; >2mm and 5mm; >5mm)= (1; 2; 14) vs (4; 4; 3), 16 
p=0.01] and shortened the duration required for resolving the stricture [29 days vs 78 days, 17 
p=0.04] even when stricture developed. There was no complication associated with 18 
preventive EBD procedure. 19 
Conclusions: Preventive EBD is an effective procedure to prevent post- EMR/ESD stricture. 20 
Preventive EBD should be considered when EMR/ESD results in a mucosal defect with a 21 
circumference greater than three-fourths of the esophageal lumen. 22 
 23 
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 2 
INTRODUCTION 3 
Endoscopic mucosal resection (EMR) is being increasingly accepted as one of the 4 
standard treatment for superficial esophageal cancer because of its minimal invasiveness and 5 
excellent survival rate.[1, 2] Furthermore, the endoscopic submucosal dissection (ESD) 6 
technique has made it possible to perform en-bloc resection of wide-spread neoplasia, such as 7 
a superficial spreading-type of esophageal squamous cell carcinoma and Barrett’s esophageal 8 
cancer.[3-7] However, extended removal of the esophageal mucosa frequently causes severe 9 
stricture.[8, 9] 10 
Esophageal stricture may markedly interfere with the oral intake of food and fluids, and 11 
thus affect the patients’ quality of life adversely. In addition, once severe esophageal stricture 12 
has developed, it is difficult to resolve the condition. While endoscopic balloon dilation 13 
(EBD) is usually indicated for benign stricture including the cicatricial stricture caused by 14 
EMR/ESD, the effect of EBD is sometimes only temporary and the stricture would reappear. 15 
[10,11] 16 
Before 2002, we performed EBD only when the patients complained of dysphagea by 17 
post-EMR/ESD stricture, and EBD was repeated until the dysphagea was completely 18 
resolved. In 2003, we reported that mucosal defects greater than three-fourths of the 19 
circumference of the esophagus after EMR are at high risk of developing esophageal stricture. 20 
[12] Since then, we started preventive EBD not to develop stricture, before post-EMR/ESD 21 
mucosal defects develop scarring. 22 
In this study, we evaluated the effectiveness of preventive EBD for the patients with 23 
superficial widespread esophageal cancer who developed mucosal defect extending more 24 
4 
than three-fourths of the circumference of the esophagus by EMR/ESD. 1 
 2 
PATIENTS AND METHODS 3 
Patients 4 
From February 1993 to June 2008, we experienced 64 consecutive patients with 5 
widespread mucosal defects greater than three-fourths of the esophageal circumference as a 6 
result of EMR/ESD for esophageal cancer. Written informed consent was obtained from all 7 
patients before performing EMR/ESD and EBD. 8 
Endoscopic resection technique 9 
To remove the lesions endoscopically, EMR [13, 14] or ESD [5-7] were performed. 10 
EBD technique 11 
All patients received administration of 17.5-35mg of pethidine hydrochloride in order 12 
to reduce the suffering from EBD procedure. All EBD procedure was performed using direct 13 
visualization and fluoroscopic monitoring. The balloon was positioned across the stenotic site, 14 
and then it was inflated carefully with double-diluted contrast agent. During the procedure, 15 
patients were closely observed with pulse, blood pressure, and oxygen saturation. When a 16 
patient experienced pain during the dilation or when a notch of the balloon placed on the 17 
stricture was gradually disappeared, dilation was stopped, and then the balloon was 18 
maintained in its inflated state and held close to the tip of the endoscope, and was pushed 19 
through the stenotic site like a bougie technique. If the notch of the balloon was rapidly 20 
expanded, suggesting a tear at the stenotic site, dilation is immediately stopped and the 21 
balloon was deflated, and then the endoscope and deflated balloon were removed. 22 
Four CRE balloon dilators (Boston Scientific Corp. Natick, MA, USA) of different 23 
sizes (10–12 mm, 12–15 mm, 15–18 mm, and 18–20 mm) were used according to the 24 
5 
severity of the stricture. A single balloon was used in each EBD session. When the endoscope 1 
could be passed through the site of the mucosal defect, a balloon of 18-20mm was used. 2 
When the stricture was less than 10 mm in diameter and larger than 5 mm, a 15–18 mm 3 
balloon was used. When the stricture was less than 5 mm in diameter and larger than 2–3 mm, 4 
a 12–15 mm balloon was used. When the stricture was a pinhole stricture, a 10–12 mm 5 
balloon was used. We did not perform preventive EBD when the luminal diameter was 6 
estimated to be greater than 20 mm because the diameter of the lumen would have been 7 
greater than that of the fully expanded balloon. 8 
In this study, we defined the EBD procedure performed immediately after EMR/ESD as 9 
“preventive EBD” and that after the development of post-EMR/ESD cicatricial stricture as 10 
“conventional EBD”. 11 
Protocol of the preventive EBD and conventional EBD 12 
Preventive EBD was commenced within one week after the EMR/ESD and repeated 13 
weekly until the complete healing of mucosal defect was observed (Fig 1). Patients consumed 14 
a regular diet during the period of mucosal healing and weekly preventive EBD. 15 
If the post-EMR/ESD mucosal defects became scarred with stricture despite repeated 16 
preventive EBD, conventional EBD was given repeatedly until the stricture was completely 17 
resolved. The time interval of conventional EBD depended on patients’ symptom such as 18 
dysphagea (usually 2 to 4 weeks). The strategy of conventional EBD has not been changed 19 
throughout this study period, therefore, the time interval of conventional EBD is not different 20 
between two groups. 21 
Definition of the stricture 22 
“Stricture” was defined when a standard 11-mm-diameter endoscope (Q240, 1T240; 23 
Olympus Optical Co. Ltd., Tokyo, Japan) could not be passed through the site, or when the 24 
patients complaint of dysphagea. Whereas, “complete resolution of the stricture” was defined 25 
6 
when a standard diameter endoscope could be passed through the site, and patients’ symptom 1 
of dysphagia were completely relieved. 2 
In each EBD sessions in all cases, diameter of stricture was measured by comparing 3 
with the diameter of inflated balloon under the fluoroscopic monitoring, and it was classed 4 
into 3 groups: 2mm; >2mm and 5mm; >5mm. The duration required for resolving the 5 
stricture was defined as the time interval between the day when the stricture was first 6 
observed and the day of complete resolution. 7 
Evaluation of preventive EBD 8 
The efficacy of preventive EBD was evaluated retrospectively by comparing the 9 
following three points between the patients with preventive EBD and those without it (Fig 2); 10 
the occurrence rate of stricture, the diameter of stricture, and the duration required for 11 
resolving the stricture by repeated conventional EBD. 12 
Statistical analysis 13 
Fisher’s exact test, or its extension when there were more than two categories, was used 14 
for categorical variables and the Mann–Whitney U test was used for continuous variables. 15 
Cox’s proportional hazard model was used for the multivariate analysis. A p value of 0.05 16 
was considered significant. All statistical analyses were performed using the Dr. SPSS II 17 
Statistics software package (SPSS Japan Inc., Tokyo, Japan). 18 
 19 
RESULTS 20 
Patient background 21 
Among the 64 patients with mucosal defects greater than three-fourths of the 22 
circumference of the esophagus after EMR/ESD, three patients did not attend follow-up 23 
consultations, 17 received additional treatment for primary lesions (chemoradiation for deep 24 
7 
invasion of the carcinoma or EMR/ESD for local recurrence and incomplete resection), and 1 
three underwent surgical resection for metachronous gastric cancer immediately after 2 
EMR/ESD. We excluded these 23 patients because additional treatments had the potential to 3 
make the stricture worse. Finally, we used data from 41 lesions in 41 patients to evaluate the 4 
efficacy of the preventive EBD. 5 
Thirty-six lesions were removed by EMR and five lesions were removed by ESD 6 
procedure. A histopathological diagnosis of squamous cell carcinoma was found in all lesions 7 
and 40 lesions were mucosal cancers but one submucosal cancer. 8 
Of the 41 patients, 29 underwent preventive EBD and 12 did not. There were no 9 
statistical differences in the characteristics of the patients and the mucosal defects except for 10 
the endoscopic resection method between patients who underwent preventive EBD and those 11 
who did not. Because the ESD was recently established technique, there are no patients 12 
treated by ESD in the historical control group. Although the difference was not statistically 13 
significant, the rate of circumferential resections tended to be greater in conventional EBD 14 
group [10/29 (34%) vs 6/12 (50%), p=0.49]. (Table 1) 15 
Profile of preventive EBD sessions 16 
Among the 29 patients who underwent preventive EBD, the median number of 17 
preventive EBD sessions was six (range, 3–9) and the period of preventive EBD was 45 days 18 
(range, 16–65). (Table 3) 19 
Efficacy of preventive EBD 20 
The number of patients who developed stricture after EMR/ESD was significantly 21 
lower in patients who were given preventive EBD than those who were not given preventive 22 
EBD [12/29 (59%) vs 11/12 (92%), p=0.04] (Table 2). 23 
The narrowest diameter of stricture in each patient was significantly larger in patients 24 
8 
who were given preventive EBD than those who were not given preventive EBD [(2mm; 1 
>2mm and 5mm; >5mm)= (1; 2; 14) vs (4; 4; 3), p=0.01] (Table 2). 2 
The number of days to development of stricture was 23 days (21–49) in patients 3 
without preventive EBD. Similarly, in patients who were given preventive EBD, tendency of 4 
stricture development was observed within 2 weeks after EMR/ESD. However, preventive 5 
EBD could prevent the patients’ symptom such as dysphagea because dilation was performed 6 
at short intervals (once a week) in all patients. Therefore, no patients suffered from 7 
dysphagea during the preventive EBD period in this study. Since the patients with preventive 8 
EBD complained the symptom of dysphagia after the completion of weekly preventive EBD, 9 
the number of days to development of stricture was 51 days (30–72). It was significantly 10 
longer in patients who underwent preventive EBD than those who did not (p< 0.001). 11 
Seventeen patients with preventive EBD and 11 patients without preventive EBD 12 
developed esophageal stricture. Then, they were given conventional EBD repeatedly until the 13 
stricture was completely relieved. Among them, the duration required conventional EBD was 14 
significantly shorter in patients given preventive EBD than in those not given it (29 days vs 15 
78 days; p=0.04). The number of conventional EBD sessions was smaller in patients with 16 
preventive EBD than in those without it, although the difference was not statistically 17 
significant (2 times vs 4.5 times; p=0.5) (Table 3).  18 
The number of total EBD sessions was greater in patients with preventive EBD than in 19 
those without it, however, the difference was not statistically significant (8 times vs 4.5 times; 20 
p=0.42) (Table 3). 21 
Safety of EBD procedure 22 
Among a total of 166 preventive EBD sessions for 29 patients, no complication 23 
occurred during the procedure (complication rate of preventive EBD: 0%). Among a total of 24 
189 conventional EBD sessions for 28 patients, a perforation was occurred in one 25 
9 
conventional EBD session in one patient (0.5% per total conventional EBD sessions, 3.6% 1 
per patient). The patient was immediately hospitalized and administered intravenous 2 
antibiotics. The patient had no symptoms or signs of mediastinitis. The fasting period was 3 
three days and hospital stay was only one week after causal EBD. No other major 4 
complication occurred. 5 
Clinical course of all patients after EMR/ESD 6 
Follow up period was calculated between the day of EMR/ESD and the day of patients’ 7 
final visit. After the complete resolution of stricture, endoscopic examination was performed 8 
every 6 months in all patients. Median follow up period of all patients was 84 months. There 9 
were no patients who suffered from dysphagea due to the recurrence of stricture. 10 
Risk of stricture 11 
Risk factors for stricture among patients with preventive EBD 12 
The method of endoscopic resection (EMR) and the longitudinal length of mucosal 13 
defect (>30 mm in length) were significantly associated with the increased risk for 14 
development of stricture by multivariate analysis (Odds ratio: 20.8, 95%CI 1.3-328.9 and 15 
12.7, 95%CI 1.3-126.9, respectively). Circumferential mucosal defects showed a higher rate 16 
of stricture than semi-circumferential mucosal defects; however, the difference was not 17 
statistically significant (Odds ratio: 3.0, 95%CI 0.2-40.5). (Table 4) 18 
 19 
DISCUSSION 20 
Technically, extended esophageal mucosal resection could be performed. However, the 21 
development of the esophageal stricture is one of the most important problems to be solved. 22 
To date, there are no well-established methods to prevent the stricture after EMR/ESD. If we 23 
10 
can prevent the development of the stricture after EMR/ESD by preventive EBD, the ability 1 
of the patients’ oral intake would be dramatically improved.  2 
In this study, we demonstrated that the preventive EBD reduced the incidence of 3 
esophageal stricture in patients who underwent an extensive EMR/ESD. In our preventive 4 
EBD protocol, EBD was performed once a week for about 6 weeks [median; 44 days (16-65 5 
days)] until the mucosal defect completely developed scar. Because of this strategy, the 6 
number of EBD sessions tended to be greater. Although it did not reach statistical 7 
significance (p=0.42), the total number of EBD sessions was nearly twice as high compared 8 
to the conventional EBD group (8.0 vs 4.5). However, the narrowest diameter of stricture was 9 
significantly mild in the preventive EBD group compared to the group without it (Table 2), 10 
while 60% of the patients in the preventive EBD group develop stricture. Clinically, the 11 
severity of the stricture is very important, because it critically affects the oral intake condition. 12 
Furthermore, the preventive EBD shortened the period to relieve the stricture even when the 13 
stricture was developed. These data indicated that the preventive EBD was a beneficial 14 
method, and thus should be considered to perform for the patients who underwent extensive 15 
EMR/ESD as a supportive treatment. 16 
Perforation and massive bleeding were the most severe complications during the EBD 17 
procedure. However, there was no complication associated with preventive EBD procedure in 18 
this study. Thus, we could conclude that the preventive EBD was a feasible procedure. Not to 19 
develop perforation, we carefully performed preventive EBD under fluoroscopic monitoring, 20 
to confirm with both of the size of the stricture and the inflated balloon. When patients 21 
complained of pain or when the balloon expanded exponentially, we stopped dilating the 22 
balloon immediately not to develop deep tear or perforation.  23 
There were some imbalances of the characteristics of mucosal defect between two 24 
groups; the rate of circumferential resections [10/29 (34%) vs 6/12 (50%), p=0.49] and the 25 
11 
rate of ESD resections [5/29 (17%) vs 0/12 (0%), p<0.001]. Although the difference of the 1 
rate of circumferential resections was not statistically significant, the possibility that the 2 
results of this study might be influenced by the difference cannot be denied. However, the 3 
“circumferential resection” and “non-circumferential resection” were not associated with the 4 
risk of development of stricture by the multivariate analysis even in the preventive EBD 5 
group. Therefore, it seemed that the imbalance about the rate of circumferential resection 6 
between two groups was not a major problem. As for the different rate of ESD resections, 7 
there are no patients treated by ESD in the historical control group because the ESD was 8 
recently established technique. These imbalances between two groups are unavoidable 9 
limitations of the retrospective review with small sample size. 10 
The rate for stricture was lower in patients who underwent ESD than those who 11 
received EMR [1/5 (20.0%) vs 16/24 (66.7%), p=0.03]. Although the reason for this 12 
difference is unknown, one possibility is that the potent cautery effect of EMR compared to 13 
that of ESD might cause more severe submucosal injury resulting in an increased risk for 14 
development of stricture. [15] Clarification of the precise mechanisms for developing 15 
stricture after EMR/ESD is warranted in future studies. In addition, the difference of rate for 16 
stricture between two groups might be influenced by the lower rate for stricture in ESD 17 
patients. However, there are no ESD patients who did not undergo preventive EBD, it is 18 
therefore impossible to evaluate the real influence from ESD patients for the results of this 19 
study. 20 
Temporary stent placement may also be a promising strategy for preventing 21 
post-EMR/ESD stricture. Self-expandable removable stents or biodegradable stents have 22 
been reported to be useful for the treatment of benign stricture such as anastomotic stricture 23 
and cicatricial stricture by esophagitis. [16] However, there has been no report on the use of 24 
self-expandable removable stents for preventing the post-EMR/ESD stricture. Although the 25 
12 
biodegradable stents have been reportedly applied for prevention of the post-EMR/ESD 1 
stricture, a small number of patients, short-term follow-up periods, and a high frequency of 2 
stent migration obscured its usefulness. [17, 18] Thus, further evaluation of these methods is 3 
required to compare their usefulness with the EBD. 4 
The multivariate analysis in patients with preventive EBD revealed that the longer 5 
longitudinal mucosal defects (>30mm) was the significant risk factor for development of the 6 
stricture; on the other hand, the circumferential mucosal defect was not a significant risk 7 
factor. To avoid the treatment induced esophageal stricture, these data are informative when 8 
we select the treatment modalities for the extended esophageal cancer; such as EMR/ESD, 9 
chemoradiotherapy, radiotherapy or surgical resection. If patients prefer the remaining the 10 
sufficient ability of oral intake, extensive EMR/ESD should not be indicated, because the 11 
long term EBD would be needed and the symptom of dysphagia afflicts the patients. 12 
In conclusion, preventive EBD could be a useful and acceptable strategy to reduce the 13 
incidence of post-EMR/ESD stricture. Because there is no other effective method to prevent 14 
stricture after extensive EMR/ESD at present, preventive EBD should be considered for all 15 
patients who undergo extensive EMR/ESD. While almost 60% of patient developed stricture 16 
despite the preventive EBD, the severity of the stricture was clearly reduced even when the 17 
stricture was developed. Since the number of patients in this study is rather small, and 18 
moreover, this was the retrospective study, a prospective study with a large number of cases 19 
is required to confirm the effectiveness of preventive EBD procedure for the prevention of 20 
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FIGURE LEGENDS 1 
Figure 1. A representative case who received preventive EBD after a 2 
semi-circumferential ESD.  3 
(a) Semi-circumferential mucosal defect immediately after the ESD. 4 
(b) Mucosal defect one week after the ESD. The site gradually developed scarring with mild 5 
stricture. 6 
(c) Mucosal defect one month after the ESD. The site developed scarring furthermore, but the 7 
stricture was mild. 8 
(d) Post-ESD site two months after the ESD. The complete healing of the post-ESD mucosal 9 
defect was observed without stricture. The endoscope could be passed through the site and 10 
the patient did not complain of any symptoms associated with esophageal stricture. 11 
 12 
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Table 1. Comparison of the characteristics of mucosal defects after endoscopic 
resection in patients with and without preventive EBD 
  Preventive EBD 





 male 28 11 
0.50 
 female 1 1 
     
Age  
 median (range) 64 years (50–74) 60 years (48–80) 0.21 
     
Circumference of the lumen 
 Circumferential 10 6 
0.49 
 Semi-circumferential 19 6 
     
Depth of resected lesion 
 Mucosa 28 12 
0.34 
 Submucosa 1 0 
     
Location 
 Upper 3 1 
0.30  Middle 13 5 
 Lower 13 6 
     
Length of mucosal defect 
 30 mm or less 6 4 
0.30 
 more than 30 mm 23 8 
     
 median (range) 40 mm (10–110) 45 mm (20–70) 0.38 
     
Endoscopic resection procedure 
17 
 EMR 24 12 
<0.001 
 ESD 5 0 
     
Number of patients are shown unless specified 





Table 2. Comparison of the occurrence rate and the diameter of esophageal 
stricture between patients with and without preventive EBD 
 Preventive EBD 
p value 
 (+) (–) 
    







    
The narrowest diameter of the stricture 















     
Number of patients are shown unless specified 
†
Median (range) 





Table 3. Comparison of the duration and the number of EBD sessions required for 
resolving the stricture by conventional EBD between patients with and without 
preventive EBD 
 Preventive EBD 
p value 
 (+) (–) 
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Number of patients are shown unless specified 
†
Median (range) 





Table 4. Predictive factors for development of stricture after endoscopic 
resection in patients who received preventive EBD 
 Odds Ratio (95% CI) p value 
Method of Endoscopic resection 
ESD 1.0 (reference) 
0.03 
EMR 20.8 (1.3–328.9) 
Longitudinal length of mucosal defect involving over three-fourth of the esophageal 
circumference 
   30 mm 1.0 (reference) 
0.03 
   30 mm 12.7 (1.3–126.9) 
Circumference of mucosal defect 
Semi-circumferential 1.0 (reference) 
0.4 
   Circumferential 3.0 (0.2–40.5) 
   
EBD: endoscopic balloon dilation 
 2 
